Startseite Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
Artikel Open Access

Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S

  • Zedong Cai , Xie Huang und Wei He EMAIL logo
Veröffentlicht/Copyright: 14. Juni 2019

Abstract

C24H23FN2O4S, orthorhombic, Pbca (no. 19), a = 14.3646(18) Å, b = 15.5927(19) Å, c = 19.645(3) Å, V = 4400.1(10) Å3, Z = 8, Rgt(F) = 0.0349, wRref(F2) = 0.0982, T = 296(2) K.

CCDC no.: 1889127

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Block
Size:0.34 × 0.25 × 0.14 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.19 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:25.1°, >99%
N(hkl)measured, N(hkl)unique, Rint:20955, 3916, 0.025
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3324
N(param)refined:290
Programs:SHELX [1], Bruker [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.64923(3)0.23860(3)0.53719(2)0.04382(14)
F10.56183(7)0.19174(7)0.34211(6)0.0596(3)
N10.84621(11)0.22597(10)0.61493(8)0.0564(4)
N20.67534(10)0.22113(8)0.45801(7)0.0436(3)
O10.88241(11)0.18576(9)0.56947(8)0.0724(4)
O20.84328(15)0.20273(11)0.67345(8)0.1040(7)
O30.67228(9)0.16309(7)0.57439(6)0.0547(3)
O40.55706(8)0.27155(8)0.53861(7)0.0596(3)
C10.80758(12)0.31134(10)0.59977(8)0.0440(4)
C20.85969(13)0.37999(13)0.62181(9)0.0574(5)
H20.91700.37100.64260.069*
C30.82649(14)0.46174(12)0.61289(10)0.0610(5)
H30.86160.50850.62720.073*
C40.74157(13)0.47428(11)0.58296(10)0.0560(5)
H40.71860.52970.57780.067*
C50.68984(12)0.40578(10)0.56049(8)0.0461(4)
H50.63230.41540.54010.055*
C60.72223(11)0.32248(9)0.56777(8)0.0390(3)
C70.65041(13)0.28694(11)0.40770(9)0.0505(4)
H7A0.69830.33070.40640.061*
H7B0.59230.31400.42070.061*
C80.64032(12)0.24653(11)0.33812(9)0.0483(4)
C90.72395(12)0.19219(10)0.31941(8)0.0455(4)
H9A0.77630.23000.31070.055*
H9B0.71030.16200.27740.055*
C100.75306(11)0.12599(10)0.37353(7)0.0390(3)
C110.76125(11)0.17418(10)0.44172(8)0.0414(4)
H11A0.77440.13340.47780.050*
H11B0.81280.21420.43930.050*
C120.61871(16)0.31316(14)0.28417(11)0.0692(6)
H12A0.61060.28540.24100.104*
H12B0.66920.35330.28130.104*
H12C0.56260.34300.29610.104*
C130.68651(11)0.04841(10)0.37521(8)0.0396(3)
C140.63639(12)0.02348(11)0.43217(9)0.0506(4)
H140.63880.05680.47140.061*
C150.58293(14)−0.05027(12)0.43152(11)0.0616(5)
H150.5501−0.06590.47040.074*
C160.57754(14)−0.10070(12)0.37467(11)0.0607(5)
H160.5414−0.15020.37460.073*
C170.62658(13)−0.07693(12)0.31754(10)0.0571(5)
H170.6235−0.11040.27840.068*
C180.68040(12)−0.00358(11)0.31804(8)0.0487(4)
H180.71340.01140.27910.058*
C190.85073(10)0.08953(10)0.35946(8)0.0399(3)
C200.88818(11)0.03089(10)0.40516(9)0.0464(4)
H200.85440.01630.44390.056*
C210.97393(12)−0.00622(11)0.39462(9)0.0496(4)
H210.9980−0.04430.42650.060*
C221.02365(12)0.01291(13)0.33722(9)0.0568(5)
H221.0807−0.01330.32910.068*
C230.98860(14)0.07077(15)0.29204(10)0.0712(6)
H231.02240.08440.25310.085*
C240.90320(13)0.10971(14)0.30321(9)0.0610(5)
H240.88110.15000.27220.073*

Source of material

The mixture solution of (diacetoxyiodo)benzene and fluoroboric acid in CH2Cl2 was stirred at room temperature for 10 min and N-(4-methyl-2,2-diphenylpent-4-en-1-yl)-2-nitrobenzenesulfonamide was added to continue the reaction for 10 min. The mixture was purified by flash column chromatography (petroleum ether/ethyl acetate = 20/1) to afford the title compound.

Experimental details

The Uiso values of the hydrogen atoms of methyl groups were set to 1.5 Ueq(C). Besides, the Uiso values of phenyl, methylene hydrogen atoms were set to 1.2 Ueq(C).

Comment

Fluorine-containing compounds are important building blocks for the synthesis of bioactive molecules [3], [4], [5]. The title structure can easily be deproted of sulfonyl protection [6], and then it could be transformed into a range of compounds containing a piperidine ring and a fluorine atom [7], [8], [9], [10], [11], [12]. These compounds have a wide range of biomedical activities.

The title structure contains a chair-type piperidine ring similar to the literature [13]. The angle between the fluorine atom and the methyl group attached to the C8 carbon atom on the piperidine ring is 106.79(15)°. The dihedral angles between the plane 1 of phenyl (C1, C2, C3, C4, C5 and C6) and the plane 2 of sulfonyl group (O3, S1 and O4), the plane 3 of nitryl (O1, N1 and O2) are 55.0(1)°, 75.2(1)°, respectively. Besides, the dihedral angle between the plane 2 and plane 3 is 52.8(1)°. The dihedral angle between two phenyl rings directly connected the piperidine ring is 83.534(55)°.

Acknowledgements

This work is supported by Shaanxi Province Key Research and Development Program (S2019-YF-ZDCXL-ZDLSF-0138).

References

1. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

2. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2009).Suche in Google Scholar

3. Asahina, Y.; Takei, M.; Kimura, T.; Fukuda, Y.: Synthesis and antibacterial activity of novel pyrido[1,2,3-de][1,4]benzoxazine- 6-carboxylic acid derivatives carrying the 3-cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl group as a C-10 substituent. J. Med. Chem. 51 (2008) 3238–3249.10.1021/jm701428bSuche in Google Scholar PubMed

4. Tsai, T.; Yeh, T.; Chen, X.; Hsu, T.; Jao, Y.; Huang, C.; Song, J.; Huang, Y.; Chien, C.; Chiu, J.; Yen, S.; Tang, H.; Chao, Y.; Jiaang, W.: Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein. J. Med. Chem. 53 (2010) 6572–6583.10.1021/jm1002556Suche in Google Scholar PubMed

5. Sharma, M.; Gupta, M.; Singh, D.; Kumar, M.; Kaur, P.: Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors. Chem. Biol. Drug Des. 82 (2013) 156–166.10.1111/cbdd.12142Suche in Google Scholar PubMed

6. Tamaddon, F.; Nasiri, A.; Farokhi, S.: CsF-Celite as an efficient heterogeneous catalyst for sulfonylation and desulfonylation of heteroatoms. Catal. Commun. 12 (2011) 1477–1482.10.1016/j.catcom.2011.04.005Suche in Google Scholar

7. Böhm, H.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst-Sander, U.; Stahl, M.: Fluorine in medicinal chemistry. ChemBioChem 5 (2004) 637–643.10.1002/cbic.200301023Suche in Google Scholar PubMed

8. Hagmann, W. K.: The many roles for fluorine in medicinal chemistry. J. Med. Chem. 51 (2008) 4359–4369.10.1021/jm800219fSuche in Google Scholar PubMed

9. Muller, K.; Faeh, C.; Diederich, F.: Fluorine in pharmaceuticals: looking beyond intuition. Science 317 (2007) 1881–1886.10.1126/science.1131943Suche in Google Scholar PubMed

10. Schweizer, E.; Hoffmann-Röder, A.; Schärer, K.; Olsen, J. A.; Fäh, C.; Seiler, P.; Obst-Sander, U.; Wagner, B.; Kansy, M.; Diederich, F.: A fluorine scan at the catalytic center of thrombin: C-F, C-OH, and C-OMe bioisosterism and fluorine effects on pKa and logD values. ChemMedChem 1 (2006) 611–621.10.1002/cmdc.200600015Suche in Google Scholar PubMed

11. Martino, R.; Gilard, V.; Desmoulin, F.; Malet-Martino, M.: Interest of fluorine-19 nuclear magnetic resonance spectroscopy in the detection, identification and quantification of metabolites of anticancer and antifungal fluoropyrimidine drugs in human biofluids. Chemotherapy 52 (2006) 215–219.10.1159/000094744Suche in Google Scholar PubMed

12. Sun, S.; Adejare, A.: Fluorinated molecules as drugs and imaging agents in the CNS. Curr. Top. Med. Chem. 6 (2006) 1457–1464.10.2174/156802606777951046Suche in Google Scholar PubMed

13. Prasad, S. B. B.; Naveen, S.; Anandakumar, C. S.; Vinaya, K.; Gowda, N. S. L.; Sridhar, M. A.; Prasad, J. S.; Rangappa, K. S.: Synthesis and crystal structure of 1-(2-nitro-benzenesulfonyl)-piperidin-4-yl-diphenyl-methanol. Mol. Cryst. Liq. Cryst. 482 (2008) 145–154.10.1080/15421400801914988Suche in Google Scholar

Received: 2019-04-25
Accepted: 2019-06-05
Published Online: 2019-06-14
Published in Print: 2019-11-26

©2019 Zedong Cai et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of [aqua[2,2′-(1,2-phenylene)bis(1H-imidazole-4-carboxylato-5-carboxy)-κ4N3,N3,O4,O4] zinc(II)] monohydrate, C16H10N4O9Zn⋅H2O
  3. Crystal structure of ethyl 3-(4-methoxyphenyl)-5-methylcarbamoyl-1H-pyrazole-4-carboxylate, C15H17N3O4
  4. 7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-N-phenyl-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbothioamide–dimethylformamide (2/1), C27H23F2N3S, 0.5(C3H7NO)
  5. Crystal structure of 4,4′-(hydrazonomethylene)diphenol dihydrate, C13H16N2O4
  6. Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
  7. Crystal Structure of tris(tetrakis{1-vinyl-1H-imidazole-κN}copper(II)) bis[tri-μ2-bromido-tetrabromido-bis(1-vinyl-1H-imidazole-κN)tetracopper(I)], C80H96N32Cu11Br14
  8. Crystal structure of (E)-2-(3,6-bis(diethylamino)-9H-xanthen-9-yl)-N′-(quinoxalin-2-ylmethylene)benzohydrazide, C37H36N6O2
  9. Crystal structure of 4-(1-phenylimidazo[1,5-a]pyridin-3-yl)benzoic acid (C20H14N2O2)
  10. Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
  11. Crystal structure of dimethyl 3,12-dibenzyl-6,10-diphenyl-3,12-diazapentacyclo [6.3.1.02.7.04.11.05.9]-dodecane-7,11-dicarboxylate — acetone (2/1), C40H38N2O2 ⋅ 0.5C3H6O
  12. Crystal structure of poly[(μ2-2-(1H-1,2,4-triazol-1-yl)benzoato-κ4O:O′:N:N′)silver(I)] monohydrate, C9H8AgO3N3
  13. Crystal structure of poly[(μ2-9H-carbazole-3,6-dicarboxylate-κ4O1,O2:O3,O4)(μ2-1,3-di(pyridin-4-yl)propane-κ2N:N)cadmium(II)]monohydrate, C27H23N3O5Cd
  14. The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir
  15. The crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfonyl)-1H-pyrazole-3-carboxamide, C12H6N4Cl2F6O3S
  16. Synthesis and crystal structure of poly[(μ2-nitrato-κ4O,O′:O′,O′′)-nitrato-κO-(μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)cadmium(II)], C14H14N6O6Cd
  17. Crystal structure of ethyl (Z)-(4-oxo-4-phenylbut-2-en-2-yl)glycinate, C14H17NO3
  18. Halogen bonds in the crystal structure of 5-bromo-3,4′-bipyridine – 1,4-diiodotetrafluorobenzene (2/1), C26H14Br2F4I2N4
  19. Crystal structure of bis(2,2′-bipyridine-κ2N,N′)-tetrakis(μ2-3-(phenylsulfonamido)propanoato-κ2O:O′)-bis(3-(phenylsulfonamido)propanoato-κ2O,O′)digadolinium(III) – 2,2′-bipyridine (1/1), C84H84Gd2N12O24S6
  20. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ2O:O′)bis(μ2-pyrazin-κ2N:N′)silver(I)], C14H16Ag2N5O8S2
  21. The crystal structure of 1,6-di-tert-butyl-1,1,3,3,4,4,6,6-octamethyl-2,2,5,5-tetrakis (trimethylsilyl)hexasilane, C28H78Si10
  22. Crystal structure of discandium triruthenium tetrasilicide, Sc2Ru3Si4
  23. Crystal structure of poly[(μ2-4-amino-1,5-naphthalenedisulfonato-κ4O,N:O′, N′)bis(μ2-hexamethylenetetramino-κ2N;N′)silver(I)], {C22H30Ag2N9O6S2}n
  24. Crystal structure of diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-κ4O,O′,N,N′)]zinc(II) dihydrate, C13H18N4O12Zn
  25. The crystal structure of poly [(μ3-N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide-κ3-O:N:N′)-(p-toluenesulfonato-κ2O,O′)silver(I)], C25H27Ag1N4O5S
  26. The crystal structure of 1,2-bis(3-bromophenoxy) ethane, C14H12Br2O2
  27. The crystal structure of 4-(pyren-1-yl)butyl-3-nitrobenzoate, C27H21NO4
  28. Crystal structure of bis[(2-(4-chlorophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ1O) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Cl2N4NiO8
  29. The crystal structure of 1,5-dinitro-2,3,4-trichlorobenzene, C6H1Cl3N2O4
  30. The crystal structure of the solid solution of 3,5-dinitropyrazole and 4-chlorine-3,5-dinitropyrazole, C3H1.24Cl0.76N4O4
  31. The cocrystal structure of 4-nitropyrazole — acetic acid (1/1), C5H7N3O4
  32. The crystal structure of propan-2-one O-(2,4,6-trinitrophenyl) oxime, C9H8N4O7
  33. The crystal structure of ethyl 2-(3-(2-ethoxy-2-oxoethyl)benzo[d] thiazol-2(3H)-ylidene)acetate, C15H17NO4S
  34. Crystal structure of (acetic acid-κ1O)-bis(μ2-2-chlorobenzoato-κ2O:O′)-(2-chlorobenzoato-κ1O)-(μ2-hydroxy-κ2O:O)-bis(1,10-phenanthroline-κ2N,N′)dimanganese(II) — methanol (1/1), C48H37Cl3Mn2N4O10
  35. Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
  36. Crystal structure of chlorido-(5-acetyl-2-(5-methylpyridin-2-yl)benzen-1-ido-κ2C,N)-pyridine-κN-palladium(II), C19H17ClN2OPd
  37. Crystal structure of (4-methyl-benzoato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C24H45ClN4NiO7
  38. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) 1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl(potassium, rubidium) — ammonia (1/2), [K0.3Rb0.7(18-crown-6)]Cp*⋅2 NH3, C22H45K0.3N2O6Rb0.7
  39. Crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3-nitrobenzylidene)piperidin-4-one — dichloromethane (2/1), C51H38Cl2F2N6O14S2
  40. Crystal structure of (E)-N′-((1,6-dihydropyren-1-yl)methylene)isonicotinohydrazide — methanol (1/1), C24H19N3O2
  41. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ3N,O:O′)-(μ4-hexamethylenetetramino-κ4N:N′:N′′:N′′′)disilver(I)] monohydrate, C12H21Ag2N5O8S2
  42. Crystal structure of bis(acridin-10-ium) 2,5-dihydroxyterephthalate — 2,5-dihydroxyterephthalic acid (1/1), C21H15NO6
  43. The crystal structure of 1,12-diazaperylene, C18H10N2
  44. Crystal structure of 1-(5-(4-chlorophenyl)-3-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one, C17H14N2OFCl
  45. Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
  46. The crystal structure of tetrachlorido-bis{1,3-bis(2,6-diisopropylphenyl)-1H-3λ4-imidazol-2-yl}-(μ2-pyrimidine-κ2N:N′)dipalladium(IV) — dichloromethane (1/2), C60H80Cl8N6Pd2
  47. The crystal structure of (E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-yl 4-nitrobenzoate, C22H19NO7
  48. Crystal structure of 3-methyl-N-(pyrimidin-5-ylmethyl)pyridin-2-amine, C11H12N4
  49. The crystal structure of 2,5-dichloroterephthalic acid dihydrate, C8H8Cl2O6
  50. The crystal structure of 2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine — dimethylformamide (1/1), C33H28N10O
  51. Crystal structure of N-(adamantan-1-yl)-5-(dimethylamino)naphthalene-1-sulfonamide, C22H28N2O2S
  52. Crystal structure of poly[diaqua-(μ4-4-(3,5-dicarboxy-κ1O-phenoxy)phthalato-κ3O:O′:O′)cadmium(II)], C16H12CdO11
  53. Crystal structure of poly[diaqua-bis(μ2-3-((1H-imidazol-1-yl)methyl)benzoato-κ2N:O)manganese(II)], C22H22MnN4O6
  54. Crystal structure of 9-(3-phenoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione, C25H23NO3
  55. The crystal structure of poly[(μ3-2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine-k3N:N′:N′′)-(nitrato-k2O,O)-(nitrato-k1O)zinc(II)] - N,N-dimethylacetamide (1/2), C38H39N13O8Zn
  56. Crystal structure of poly[(μ7-4-(3,5-dicarboxylatophenoxy)phthalato)-(1,10-phenanthroline-κ2N,N′)dizinc(II)], C28H14N2O9Zn2
  57. The crystal structure of methyl 2-(benzylamino)-5-(benzyloxy)benzoate, C22H21NO3
  58. Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanoplatinate(II), C14H24N8PdPt
  59. Crystal structure of (pyridine-2-carboxylato-κ2N,O)-[2-(2-pyridyl)phenyl-κ2N,C1]palladium(II), C17H12N2O2Pd
  60. Crystal structure of (cyclohexane-1,4-diammonium) 4-[(4-carboxylatophenyl)disulfanyl]benzoate dimethylsulphoxide hydrate (1/1/1/1), [C6H16N2]2+[C14H8O4S2]2−⋅C2H6OS⋅H2O
  61. Crystal structure of the 2:1 co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-bromobenzoic acid, 2(C14H10O4S2)⋅C7H5BrO2
  62. Crystal structure of chlorido-dimethyl-(phenylpiperazine-1-carbodithioato-κ2S,S′)tin(IV), C13H19ClN2S2Sn
  63. Crystal structure of (N-n-butyl, N-methyl-dithiocarbamato-κ2 S,S′)-chlorido-dimethyl-tin(IV), C8H18ClNS2Sn
  64. Crystal structure of (2,2′-bipyridyl)bis(4-bromobenzyl)dibromidotin(IV), C24H20Br4N2Sn
  65. Crystal structure of (2,2′-bipyridyl)bis(4-chlorobenzyl)dichloridotin(IV), C24H20Cl4N2Sn
  66. Crystal structure of N-methyl-N-phenyl(methylsulfanyl)carbothioamide, C9H11NS2
  67. Crystal structure of 4-phenylpiperazin-1-ium (4-phenylpiperazin-1-yl)carbothioylsulfanide, [C10H15N2][C11H13N2S2]
  68. Crystal structure of catena-{di-aqua-sodium [n-butyl(methyl)carbamothioyl]sulfanide}n, [C6H16NNaO2S2]n
  69. Crystal structure of (2-([1,1-bis(hydroxymethyl)-2-oxyethyl]iminomethyl)-5-(n-decyl)phenolato)-dimethyl-tin(IV), C23H39NO5Sn
  70. Crystal structure of 4-chloro-N′-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]benzohydrazide – a Z′ = 3 structure, C16H15ClN2O3
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0302/html
Button zum nach oben scrollen